Patents Examined by Robert Benson
  • Patent number: 4837003
    Abstract: Methods and reagents for attaching radionuclide metal ions to antibody fragments are disclosed. A coupling agent is employed which contains a maleimidyl group linked, through a divalent organic moiety, to a group capable of forming a chelate complex with the radionuclide metal ion. Antibody fragments labeled with radionuclide metal ions by the disclosed procedure are useful for in vivo diagnostic or therapeutic applications.
    Type: Grant
    Filed: September 13, 1984
    Date of Patent: June 6, 1989
    Assignee: Mallinckrodt, Inc.
    Inventor: Robert A. Nicolotti
  • Patent number: 4837395
    Abstract: Methods and compositions are provided for assays involving members of a specific binding pair ("sbp members") and members of a signal producing system ("sps members"). The signal producing system is capable of producing a detectible signal in relation to the presence or amount of an analyte in a sample suspected of containing the analyte. Exemplary of sps members are enzymes and enzyme substrates, which react with each other to produce a signal. The improvement of the present invention comprises temporarily delaying the production of the signal without subsequent reagent addition. The delay can be achieved by employing an inhibitor which can be an alternate substrate for the enzyme or a compound which reacts with the product of the enzyme and its substrate in an effective amount.
    Type: Grant
    Filed: May 10, 1985
    Date of Patent: June 6, 1989
    Assignee: Syntex (U.S.A.) Inc.
    Inventors: Sydney Leeder, Robert F. Zuk
  • Patent number: 4835268
    Abstract: Disclosed herein are derivatives of 5-(lower alkyl)-7-amino-2,3-dihydro-1,4-phthalazinedione having substituents on the amino group. The derivatives have luminescent properties which render them useful as analytical tools in clinical chemistry. Adaptation of the derivatives for luminescent immunoassay provides valuable reagents and assays with outstanding sensitivity.
    Type: Grant
    Filed: May 7, 1987
    Date of Patent: May 30, 1989
    Assignee: Universite Laval
    Inventors: Alain Belanger, Paul Brassard
  • Patent number: 4833073
    Abstract: Novel cannabinol derivatives are provided which can be used in improved immunoassays for the detection in blood or urine samples of cannabinol metabolites.
    Type: Grant
    Filed: January 27, 1987
    Date of Patent: May 23, 1989
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Alan J. McNally, Alan Schwartz, Magdalena Usategui
  • Patent number: 4830961
    Abstract: A method and test kit for selectively staining histamine or histamine blocker sites on mammalian cells is described. Novel fluorescently labeled histamines or histamine blocker compounds are described. The method allows the visualization of sites on individual cells which are receptors for the histamines or histamine blockers.
    Type: Grant
    Filed: June 5, 1986
    Date of Patent: May 16, 1989
    Assignee: Board of Governors of Wayne State University
    Inventor: Howard R. Petty
  • Patent number: 4828985
    Abstract: The invention involves polyclonal antibodies reactive with a complex of a hapten and its binding protein, wherein the antibodies are unreactive with the free hapten or free binding protein. The antibodies are useful in assays of the hapten or the binding protein.
    Type: Grant
    Filed: February 7, 1986
    Date of Patent: May 9, 1989
    Assignee: Cambridge Patent Developments Limited
    Inventor: Colin H. Self
  • Patent number: 4822733
    Abstract: Improved luminescent lifetime-resolved association assay techniques for detection of analytes in samples using two photophore-labelled probes, the photophores of which have different emissive lifetimes. One of the photophores is excitable by a modulated energy source to an excited state from which energy may be transferred to the other photophore when in close poximity thereto resulting in excitation and emission of the other photophore. Methods according to the invention involve associating the first photophore-labelled probe with the analyte and associating the second photophore-labelled probe with the analyte or first probe in a reaction mixture bringing the photophores in sufficient proximity to allow energy transfer to occur. The reaction mixture is formed, excited by the modulated energy source and monitored for emission of the photophore excited by energy transfer at a time beyond the emissive lifetime of the shorter-lived photophore.
    Type: Grant
    Filed: May 28, 1985
    Date of Patent: April 18, 1989
    Assignee: Amoco Corporation
    Inventor: Larry E. Morrison
  • Patent number: 4820632
    Abstract: The present invention is concerned with the use of aniline derivatives of the general formula: ##STR1## wherein R.sub.1 is a hydrogen atom or a lower alkyl or aryl radical, R.sub.2 is a hydrogen atom or a lower alkyl radical which can be substituted by hydroxyl, amino, carboxyl, lower alkoxycarbonyl, lower alkanoylamido, aryl lower alkyl or aryl or by a group of the structure: ##STR2## in which R.sub.5 and R.sub.6 have the meanings given hereinafter, R.sub.3 is a hydrogen or halogen atom or a carboxyl group, R.sub.4 and R'.sub.4, which can be the same or different, are hydrogen or halogen atoms, carboxyl groups or lower alkoxy radicals or lower alkyl radicals which are preferably in the m-position and R.sub.1 and R.sub.4 or R.sub.2 and R.sub.4 or R.sub.4 and R'.sub.4, when the two substituents are ortho to one another, can together form a saturated or unsaturated hydrocarbon chain containing 2 to 6 carbon atoms which can be substituted by hydroxyl or oxo groups, R.sub.
    Type: Grant
    Filed: September 10, 1985
    Date of Patent: April 11, 1989
    Assignee: Boehringer Mannheim GmbH
    Inventors: Gunter Frey, Gerd Zimmermann
  • Patent number: 4818755
    Abstract: Cardiotonic fused aromatic bicyclic ring substituted thiazole compounds and their salts, methods for increasing cardiac contractility in humans and other mammals by the use of said compounds, pharmaceutical compositions including said compounds and methods for compound preparation.
    Type: Grant
    Filed: July 28, 1986
    Date of Patent: April 4, 1989
    Assignee: Rorer Pharmaceutical Corporaton
    Inventors: Donald E. Kuhla, Henry F. Campbell, William L. Studt, Bruce F. Molino
  • Patent number: 4812402
    Abstract: A method is described for the in vitro determination of hypersensitivity to an allergen. The method consists of adding the allergen to a sample containing basophilic leucocytes from the blood of a patient, and then measuring the amount of degranulation of the leucocytes. The allergen is added slowly and continuously, such that the threshold concentration needed to cause degranulation of sensitized leucocytes is reached sometime during the addition step and is present for a long enough period of time to allow degranulation to occur.
    Type: Grant
    Filed: February 19, 1988
    Date of Patent: March 14, 1989
    Assignee: Bio-Instructa Labkonsult
    Inventor: Tomas Nilsson
  • Patent number: 4810640
    Abstract: The present invention relates to a method of quantitative assay for 1,5-anhydroglucitol which comprises oxidizing 1,5-anhydroglucitol in an aqueous solution of a specimen in the presence of an electron acceptor to produce a compound represented by formula (1) below or a hydrate thereof represented by formula (2) below and quantitatively determining 1,5-anhydroglucitol from a consumption amount of said electron acceptor in said aqueous solution of a specimen or from a production amount of the reduction product of said electron acceptor produced or from an amount of oxidized product of 1,5-AG represented by formula (1) or formula (2).
    Type: Grant
    Filed: May 27, 1986
    Date of Patent: March 7, 1989
    Assignee: Nippon Kayaku Kabushiki Kaisha
    Inventors: Tsuneo Nakamura, Hiroshi Akanuma, Akinori Naito, Masahiko Yabuuchi, Akira Takahashi, Shigeru Tajima, Masashi Hashiba, Kazuo Kato
  • Patent number: 4810638
    Abstract: Enzyme-labeled antibody reagents wherein the enzyme and an antibody reagent, e.g., whole polyclonal or monoclonal antibody or a fragment thereof, are covalently linked through a bis-maleimidopolyalkyleneglycol bridge group. The reagents are useful in immunoassay and other methods for detecting an antigen or hapten that can be bound by the antibody reagent. The conjugates are highly stable and water soluble, and are characterized by a high degree of immunoreactivity and enzyme activity.
    Type: Grant
    Filed: July 24, 1986
    Date of Patent: March 7, 1989
    Assignee: Miles Inc.
    Inventors: James P. Albarella, Robert T. Buckler
  • Patent number: 4810629
    Abstract: The disclosure is of an improved method for the in-vitro detection and identification of viral associated immunoreactants in biological fluids including cell cultures. The improvement comprises admixing the fluid with solid, porous carrier particles bearing surface adsorbed, known immunological homolog/surfactant complexes. An agglutination reaction indicates the presence of immunoreactant corresponding to the surface adsorbed homolog.
    Type: Grant
    Filed: September 26, 1985
    Date of Patent: March 7, 1989
    Assignee: Fairleigh Dickinson Laboratories, Inc.
    Inventors: John H. Brewer, Terry L. Foster
  • Patent number: 4808522
    Abstract: A method for determination of an antigen, which comprises preparation of a onjugate by way of cross-linking of an antibody with an inorganic pyrophosphatase, reacting the resulting conjugate with the antigen to be determined attached to the surface of a solid phase, separating the solid phase from the liquid one, reacting one of said phases with a substrate represented by a salt of pyrophosphoric acid. After carrying out the reaction, a color reagent incorporating a salt of molybdic acid, a surfactant, malachite green dye and a strong inorganic acid is added to the resulting reaction mixture and the content of the antigen is determined from its optical density.
    Type: Grant
    Filed: April 23, 1986
    Date of Patent: February 28, 1989
    Assignee: Moskovsky Gosudarstvennx Universitet Imeni M. V. Lomonoso VA
    Inventors: Iosif G. Atabekov, Svetlana M. Avaeva, Alexandr A. Baikov, Alexandr V. Kulinich, Olga A. Mizenina, Vladimir N. Kasho, Irina N. Smirnova
  • Patent number: 4808518
    Abstract: Recovery of antigen from cells containing an intracellular parasite, in particular a virus, by extracting the antigen from the cells with a hypertonic salt solution. CMV antigen extracted in this manner may be supported on particles and used in an agglutination assay for CMV antibody.
    Type: Grant
    Filed: February 11, 1985
    Date of Patent: February 28, 1989
    Assignee: University of Tennessee Research Corporation
    Inventors: Preston H. Dorsett, Robert F. Naegele, Terry S. Ratcliffe
  • Patent number: 4808619
    Abstract: Compounds of the formula ##STR1## as defined in the specification, and processes for their preparation and methods of using the compounds for the treatment of hypertension in mammals, such as humans and for the treatment and/or prophylaxis of cerebrovascular disorders and/or disorders associated with cerebral senility in mammals, such as humans.
    Type: Grant
    Filed: July 30, 1986
    Date of Patent: February 28, 1989
    Assignee: Beecham Group p.l.c.
    Inventors: John M. Evans, Geoffrey Stemp, Charles D. Nicholson, Dieter Angersbach
  • Patent number: 4808582
    Abstract: Compounds of formula: ##STR1## wherein: Ar is an aromatic group; R and R.sub.1 are H or CH.sub.3 ; A represents a nitrogenized heterocyclic radical; B is OH or forms with the adjacent CO group, either an amido group, or a carbonyloxy group; R.sub.2 and R.sub.3 are H or alkyl; m=0 or 1; and n=0, 1, 2 or 3.These compounds are useful as drugs having stimulating, protecting and/or correcting activities of the cerebral functions.
    Type: Grant
    Filed: March 19, 1987
    Date of Patent: February 28, 1989
    Assignee: Delalande S.A.
    Inventors: Alain Y. Platel, Guy R. Bourgery, Patrick G. Guerret
  • Patent number: 4801504
    Abstract: Fluorescent labels comprise a polysaccharide bound to a polymeric particle which contains a fluorescent rare earth chelate. These labels can be attached to any of a variety of physiologically reactive species to provide labeled species which have improved stability in aqueous solutions. The labeled species are particularly useful in specific binding assays to determine an immunologically reactive ligand, e.g. a hapten, in either solution or dry analytical techniques.
    Type: Grant
    Filed: September 24, 1987
    Date of Patent: January 31, 1989
    Assignee: Eastman Kodak Company
    Inventors: Brent A. Burdick, Susan J. Danielson
  • Patent number: 4798807
    Abstract: Compositions of matter are described which include five monoclonal antibodies that react with dioxins and dibenzofurans, and the five hybridomas that produce these monoclonal antibodies. In addition, a method for the use of these antibodies in a sensitive immunoassay for dioxins and dibenzofurans is given, which permits detection of these pollutants in samples at concentrations in the range of a few parts per billion.
    Type: Grant
    Filed: June 24, 1986
    Date of Patent: January 17, 1989
    Assignee: The Regents of the University of California
    Inventors: Martin Vanderlaan, Larry H. Stanker, Bruce E. Watkins, Nina R. Bailey
  • Patent number: 4797490
    Abstract: 6-Fluoro-7-pyridylquinolone carboxylic esters and acids having antibacterial activity are prepared by coupling of a 2-fluorophenyl-metallic compound with a pyridyl bromide or iodide in the presence of a transition metal catalyst, nitrating and hydrogenating the pyridyl-2-fluorophenyl compound formed, introducing a substituent on the nitrogen of the amine formed, and cyclizing after reacting with a dialkyl or dibenzyl ethoxymethylene malonate to form a 6-fluoro-7-pyridyl-1,4-dihydroquinol-4-one 3-carboxylate, and hydrolyzing to the corresponding acid.
    Type: Grant
    Filed: September 15, 1986
    Date of Patent: January 10, 1989
    Assignee: Pfizer Inc.
    Inventors: Paul J. Gilligan, Paul R. McGuirk, Michael J. Witty